Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (Rac)-Zevaquenabant | 1610420-28-4 | 99.2% | C25H21ClF3N5O2S | 1 ML
SDP

Catalog No. 5000354856
Encompass_Preferred

(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R) and inducible nitric oxide synthase (iNOS) antagonist. It exhibits a Ki of 5.7 nM for CB1R and is being investigated for its potential in liver fibrosis research.

  • Functions as a CB1R and iNOS antagonist
  • Exhibits a Ki of 5.7 nM for CB1R
  • Potential for liver fibrosis research
  • Molecular weight of 547.98
  • Appearance as a white to off-white solid

Catalog No. 50-003-54856 Supplier Medchemexpress LLC Supplier No. HY14141110MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R) and inducible nitric oxide synthase (iNOS) antagonist. It exhibits a Ki of 5.7 nM for CB1R and is being investigated for its potential in liver fibrosis research.

  • Functions as a CB1R and iNOS antagonist
  • Exhibits a Ki of 5.7 nM for CB1R
  • Potential for liver fibrosis research
  • Molecular weight of 547.98
  • Appearance as a white to off-white solid

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.